Table of Contents

2019-2024 Global Gastrointestinal Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Gastrointestinal Consumption 2014-2024
  • 2.1.2 Gastrointestinal Consumption CAGR by Region
• 2.2 Gastrointestinal Segment by Type
  • 2.2.1 Prescription Gastrointestinal Drug
  • 2.2.2 OTC Gastrointestinal Drug
• 2.3 Gastrointestinal Consumption by Type
  • 2.3.1 Global Gastrointestinal Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Gastrointestinal Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Gastrointestinal Sale Price by Type (2014-2019)
• 2.4 Gastrointestinal Segment by Application
  • 2.4.1 Chronic Gastritis
  • 2.4.2 Functional Dyspepsia
  • 2.4.3 Peptic Ulcer
  • 2.4.4 Acute Gastroenteritis
  • 2.4.5 Other
• 2.5 Gastrointestinal Consumption by Application
  • 2.5.1 Global Gastrointestinal Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Gastrointestinal Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Gastrointestinal Sale Price by Application (2014-2019)

3 Global Gastrointestinal by Players

• 3.1 Global Gastrointestinal Sales Market Share by Players
  • 3.1.1 Global Gastrointestinal Sales by Players (2017-2019)
  • 3.1.2 Global Gastrointestinal Sales Market Share by Players (2017-2019)
• 3.2 Global Gastrointestinal Revenue Market Share by Players
  • 3.2.1 Global Gastrointestinal Revenue by Players (2017-2019)
  • 3.2.2 Global Gastrointestinal Revenue Market Share by Players (2017-2019)
• 3.3 Global Gastrointestinal Sale Price by Players
• 3.4 Global Gastrointestinal Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Gastrointestinal Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Gastrointestinal Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Gastrointestinal by Regions

• 4.1 Gastrointestinal by Regions
  • 4.1.1 Global Gastrointestinal Consumption by Regions
  • 4.1.2 Global Gastrointestinal Value by Regions
• 4.2 Americas Gastrointestinal Consumption Growth
• 4.3 APAC Gastrointestinal Consumption Growth
• 4.4 Europe Gastrointestinal Consumption Growth
• 4.5 Middle East & Africa Gastrointestinal Consumption Growth

5 Americas

• 5.1 Americas Gastrointestinal Consumption by Countries
  • 5.1.1 Americas Gastrointestinal Consumption by Countries (2014-2019)
  • 5.1.2 Americas Gastrointestinal Value by Countries (2014-2019)
• 5.2 Americas Gastrointestinal Consumption by Type
• 5.3 Americas Gastrointestinal Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Gastrointestinal Consumption by Countries
  • 6.1.1 APAC Gastrointestinal Consumption by Countries (2014-2019)
  • 6.1.2 APAC Gastrointestinal Value by Countries (2014-2019)
• 6.2 APAC Gastrointestinal Consumption by Type
• 6.3 APAC Gastrointestinal Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Gastrointestinal by Countries
  • 7.1.1 Europe Gastrointestinal Consumption by Countries (2014-2019)
  • 7.1.2 Europe Gastrointestinal Value by Countries (2014-2019)
• 7.2 Europe Gastrointestinal Consumption by Type
• 7.3 Europe Gastrointestinal Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Gastrointestinal by Countries
  • 8.1.1 Middle East & Africa Gastrointestinal Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Gastrointestinal Value by Countries (2014-2019)
• 8.2 Middle East & Africa Gastrointestinal Consumption by Type
• 8.3 Middle East & Africa Gastrointestinal Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Gastrointestinal Distributors
• 10.3 Gastrointestinal Customer

11 Global Gastrointestinal Market Forecast

• 11.1 Global Gastrointestinal Consumption Forecast (2019-2024)
• 11.2 Global Gastrointestinal Forecast by Regions
  • 11.2.1 Global Gastrointestinal Forecast by Regions (2019-2024)
  • 11.2.2 Global Gastrointestinal Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Gastrointestinal Forecast by Type
• 11.8 Global Gastrointestinal Forecast by Application

12 Key Players Analysis

• 12.1 AstraZenec
  • 12.1.1 Company Details
  • 12.1.2 Gastrointestinal Product Offered
  • 12.1.3 AstraZenec Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 AstraZenec News
• 12.2 Sanofi
  • 12.2.1 Company Details
  • 12.2.2 Gastrointestinal Product Offered
  • 12.2.3 Sanofi Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Sanofi News
• 12.3 Bayer
  • 12.3.1 Company Details
  • 12.3.2 Gastrointestinal Product Offered
  • 12.3.3 Bayer Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Bayer News
• 12.4 Pfizer
  • 12.4.1 Company Details
  • 12.4.2 Gastrointestinal Product Offered
  • 12.4.3 Pfizer Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Pfizer News
• 12.5 GlaxoSmithKline
  • 12.5.1 Company Details
  • 12.5.2 Gastrointestinal Product Offered
  • 12.5.3 GlaxoSmithKline Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 GlaxoSmithKline News
• 12.6 Teva
  • 12.6.1 Company Details
  • 12.6.2 Gastrointestinal Product Offered
  • 12.6.3 Teva Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Teva News
• 12.7 Zeria（Tillotts）
  • 12.7.1 Company Details
  • 12.7.2 Gastrointestinal Product Offered
  • 12.7.3 Zeria（Tillotts） Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Zeria（Tillotts） News
• 12.8 Perrigo
  • 12.8.1 Company Details
  • 12.8.2 Gastrointestinal Product Offered
  • 12.8.3 Perrigo Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Perrigo News
• 12.9 Boehringer Ingelheim
  • 12.9.1 Company Details
  • 12.9.2 Gastrointestinal Product Offered
  • 12.9.3 Boehringer Ingelheim Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Boehringer Ingelheim News
• 12.10 Purdue Pharma
  • 12.10.1 Company Details
  • 12.10.2 Gastrointestinal Product Offered
  • 12.10.3 Purdue Pharma Gastrointestinal Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Purdue Pharma News
• 12.11 C.B. Fleet
• 12.12 Abbott
• 12.13 Jiangzhong
• 12.14 Xian-Janssen

13 Research Findings and Conclusion

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.

According to this study, over the next five years the Gastrointestinal market will register a 0.9% CAGR in terms of revenue, the global market size will reach US$ 35300 million by 2024, from US$ 33600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gastrointestinal business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal market by product type, application, key manufacturers and key regions and countries.

This study considers the Gastrointestinal value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gastrointestinal consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gastrointestinal market by identifying its various subsegments.
Focuses on the key global Gastrointestinal manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastrointestinal with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gastrointestinal submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.